Valuation : InterCure Ltd.

Market Cap 197M 0 169M 159M 146M 272M 18.59B 273M 1.88B 731M 9.54B 739M 723M 30.72B P/E 2024
-4.01x
P/E 2025 -4.87x
Enterprise Value 333M 0 287M 270M 246M 461M 31.46B 462M 3.19B 1.24B 16.14B 1.25B 1.22B 52B EV / Sales 2024
1.69x
EV / Sales 2025 1.16x
Free-Float
60.83%
Yield 2024 *
-
Yield 2025 -
1 day+2.47%
1 week-5.78%
Current month-7.36%
1 month+12.15%
3 months+8.84%
6 months+23.94%
Current year+2.72%
1 week 1,603
Extreme 1603
1,794
1 month 1,255
Extreme 1255
1,862
Current year 1,126.5
Extreme 1126.5
1,862
1 year 1,126.5
Extreme 1126.5
2,834.5
3 years 1,126.5
Extreme 1126.5
6,730
5 years 1,126.5
Extreme 1126.5
13,175
10 years 734.13
Extreme 734.1278
31,589.75
Manager TitleAgeSince
Chief Executive Officer 55 23/12/2019
Director of Finance/CFO 47 29/02/2020
General Counsel - 31/03/2022
Director TitleAgeSince
Director/Board Member 50 02/09/2015
Director/Board Member 66 13/12/2014
Chairman 55 12/02/2025
Date Insider Type Main position Quantity % Market Cap. Importance
18/03/26 Other

Chief Financial Officer

539,947 0.9874%
18/03/26 Other

Director

19,046 0.0348%
18/03/26 Other

Chief Executive Officer

17,285,455 31.6113%
Change 5-day change 1-year change 3-year change Capi.($)
+2.47%-5.78%-38.72%-43.80% 63.9M
+0.86%+0.34%+9.77%+227.35% 354M
+0.63%-5.36%-27.73%-22.82% 161M
+0.51%0.00%+11.80%+99.00% 142M
+5.68%+16.25%-32.61%-39.61% 89.41M
0.00%0.00%0.00%-80.00% 25.29M
Average +1.69%-1.58%-12.91%+23.35% 139.3M
Weighted average by Cap. +1.37%-1.32%-5.66%+98.69%

Financials

2024 2025
Net sales 239M 0 206M 193M 177M 330M 22.55B 331M 2.29B 887M 11.57B 897M 877M 37.27B 270M 0 233M 219M 200M 374M 25.51B 375M 2.58B 1B 13.09B 1.01B 992M 42.17B
Net income -67.8M -0 -58.34M -54.89M -50.14M -93.8M -6.4B -94.05M -649M -252M -3.28B -255M -249M -10.58B -35.71M -0 -30.73M -28.91M -26.41M -49.41M -3.37B -49.54M -342M -133M -1.73B -134M -131M -5.57B
Net Debt 133M 0 114M 107M 98.18M 184M 12.53B 184M 1.27B 493M 6.43B 499M 488M 20.72B 136M 0 117M 110M 101M 189M 12.87B 189M 1.3B 506M 6.6B 512M 501M 21.28B
Logo InterCure Ltd.
InterCure Ltd. is an Israel-based company engaged in the medical cannabis industry. Through its wholly owned subsidiary, Canndoc Ltd., the Company cultivates, produces, processes, markets, and distributes medical cannabis products. Its operations include the development and manufacture of pharmaceutical-grade medical cannabis products produced in accordance with Good Manufacturing Practice (GMP) standards. The Company offers a range of cannabis-based products for medical use and operates across various stages of the medical cannabis value chain, including cultivation, manufacturing, logistics, distribution, and retail activities. In addition, the Company is involved in the import, export, and commercialization of medical cannabis products and related healthcare solutions in Israel and selected international markets.
Employees
285
Date Price Change Volume
04/09/26 ILA 1,662.00 +2.47% 5,273
03/09/26 ILA 1,622.00 -3.68% 10,992
02/09/26 ILA 1,684.00 -1.69% 10,537
01/09/26 ILA 1,713.00 -4.52% 8,865
31/08/26 ILA 1,794.00 +1.70% 41,094
  1. Stock Market
  2. Stocks
  3. INCR Stock